Company Number: 15208503

Analysis Date: 2025-07-29 15:31 UTC

Financial Health Assessment: EVOLAF LIMITED

---

1. Financial Health Score: D

Explanation:
EVOLAF LIMITED is a newly incorporated micro-entity with minimal financial activity and very limited assets. The company's financials show extremely low current assets (£15) and net assets (£12), with a small provision for liabilities (£3). While the company is compliant with filing requirements and active, the very low asset base and minimal working capital suggest the business is in an embryonic stage with limited financial robustness. This score reflects a fragile financial condition typical of a startup yet to establish a stable cash flow or capital base.

---

2. Key Vital Signs

Metric	Value	Interpretation
Current Assets	£15	Extremely low cash or receivables, indicating almost no liquidity on hand.
Net Current Assets	£15	Positive but negligible working capital; no buffer against short-term obligations.
Total Net Assets	£12	Very low equity base; minimal cushion to absorb losses or finance growth.
Provision for Liabilities	£3	Small estimated liabilities; manageable but proportionally significant relative to assets.
Number of Employees	1	Sole director/employee; minimal operational scale.
Company Age	~1 year	Newly formed company, likely in startup phase.
Compliance Status	Up to date	No overdue filings; good governance and regulatory compliance.
Ownership Concentration	100% owned by director	High ownership concentration, indicating centralized control but potential risk of single-person dependency.

---

3. Diagnosis

The "patient"—EVOLAF LIMITED—is in the earliest stage of its business lifecycle. The company exhibits the classic symptoms of a startup: very low asset base, minimal liquidity, and a single employee (the director) managing operations. The absence of significant current liabilities is positive, but the negligible cash or liquid assets pose a risk of immediate financial distress if operational expenses arise before revenues materialize.

The financial statements indicate no audit requirement, reflecting the micro-entity status and limited financial complexity. However, the balance sheet's "thin" nature signals that the company has yet to develop a healthy cash flow or accumulate retained earnings.

There are no signs of financial distress such as overdue filings or negative net assets, which is encouraging. However, the company's survival and growth depend heavily on the director's ability to inject funds or generate revenue swiftly. The centralized control by a single individual presents governance simplicity but also concentrates risk.

---

4. Recommendations

To improve financial wellness and avoid symptoms of distress such as cash shortages or inability to meet liabilities, the following actions are advised:

• Increase Working Capital: Seek additional funds through equity injection or short-term financing to build a cash buffer. Healthy cash flow is vital to cover operating expenses and invest in growth.

• Operational Scaling: Develop a clear business plan to generate revenues promptly. Early customer acquisition and service delivery will enhance cash inflows and strengthen financial health.

• Expense Management: Maintain lean operations initially to minimize outflows, preserving the limited cash resources.

• Governance and Risk Management: Although sole ownership simplifies decision-making, consider establishing advisory support or external oversight to mitigate risks from single-person dependency.

• Financial Monitoring: Implement regular cash flow forecasting and financial reporting to detect early warning signs and adjust plans proactively.

• Compliance Maintenance: Continue timely filing of accounts and confirmation statements to avoid penalties and maintain good standing.

---